TRPV1 and colorectal cancer: Another strategy that has been explored was the synergistic effect of silver nanoparticles (AgNPs) in enhancing the anticancer properties of 5-fluorouracil (5-FU), a chemotherapy drug commonly used in the treatment of colorectal cancer, which is characterised by TRPV1 expression [145].